| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/04/2026 | ±4.1% | +3.5% | over-priced |
| 05/05/2026 | ±3.7% | +3.0% | over-priced |
| 02/24/2026 | ±3.8% | +3.6% | over-priced |
| 11/04/2025 | ±3.1% | -1.4% | over-priced |
| 08/01/2025 | ±2.5% | -1.9% | over-priced |
| 04/28/2025 | ±5.5% | +0.1% | over-priced |
| 02/25/2025 | ±2.8% | -1.6% | over-priced |
| 10/29/2024 | ±2.8% | +0.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.76 | $1.8B | $339M |
| Q1 FY2026 | $0.51 | $1.7B | $219M |
| Q4 FY2025 | — | $1.7B | $-900M |
| Q3 FY2025 | $0.66 | $1.6B | $356M |
Invesco LTD (IVZ) reports in 7 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±3.5% earnings move while the stock actually moved 1.9% on average — the market has systematically over-priced IVZ's earnings risk. Fundamentals into the print: EPS up 2633.3% year-over-year, revenue up 20.5%. QuantLogix's live 5-factor engine currently reads IVZ as a neutral at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →